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The focus of this thesis is to study the facilitation of colorectal cancer (CRC) 
development after ingestion of food additive titanium dioxide (E171) and extend the 
current knowledge by investigating mechanisms that underlie these effects. The results 
showed that E171 induces oxidative stress in an acellular environment, DNA damage in 
vitro, gene expression changes in vitro and in vivo towards an impairment of the immune 
system, DNA repair, induction of oxidative stress, dysregulation of olfactory/GPCR 
receptor family, and facilitation of development of CRC. In addition, the relative 
contribution of the nanoparticle (NPs) (<100 nm) fraction (40% of E171) and the 
microparticle (MPs) (>100 nm) fraction (60% of E171) were investigated in vitro. Results 
showed that NPs also induce oxidative stress in an acellular environment whereas MPs 
induced oxidative stress in vitro. Both MPs and NPs provoked DNA damage and gene 
expression changes indicating effects in signalling, inflammation, immune system, 
transport, and cancer. This valorisation chapter reflects on how the scientific results 
described in this thesis can be applied to create societal value. 
 
I- Societal and economic relevance 
 The societal relevance of the present thesis is regarding the consumers. E171 is 
present in a large number of products as shown in Chapter 1 and the exposure is occurring 
every day for all age groups. Recently, consumers have become more insistent over the 
need for greater transparency in their food and drinks. These changes have propelled the 
movement to simpler and natural ingredients affecting product formulation and consumer 
purchase interest. The consumers are looking for more information and can easily find 
them on the internet. However, the related information is not necessary scientific based 
conclusions and this has an impact on the consumers. It is important that they can find the 
scientific based conclusions about the possible risks engendered by the ingestion of these 
products as shown in this thesis.  
 
Additionally, this thesis indicates a link between ingestion of E171 and 
enhancement of CRC. CRC is, worldwide, the second most common cancer in women and 
the third in men (1). With a morbidity of 614,000 cases for women and 740,000 for men, 
CRC represents 9.2% and 10% of all cancers respectively (1). CRC is also the fourth leading 
cause of cancer death in the world accounting for about 700,000 deaths in 2012. While 
taking into account the demographic projection, the global burden of CRC is estimated to 
increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030 (1). 
The distribution of CRC burden varies around the world with almost 55% of all cases and 
about 60% of all death occurring in developed regions. Indeed, incidence rates are 
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estimated to be the highest in Australia/New Zealand (32.2 and 44.8 per 100,000 women 
and men respectively) and the lowest in Western Africa (3.8 and 4.5 per 100,000 women 
and men respectively). In view of these figures and studies on the effects of diet, CRC has 
been strongly associated with the adverse effects of lifestyle and diet (2).  
 
 The economic burden of CRC was recently estimated in Spain between €20,478 
and 27,000€ per patient for 5 years after diagnosis (3). A rough estimation according to 
the number of cancer worldwide (1.4 million in 2012) would show a global economic 
burden between €5.5 and 7.3 billion per year for the year 2012 and between €9.0 and 
11.9 billion per year for the year 2030. This estimation does not include extra costs due to 
the side effects of the chemotherapy which were estimated monthly in US per patient at 
$1,480 for hematologic, $1,253 for respiratory, and $1,213 for endocrine and metabolic 
adverse effects (4). 
 
 The results of this thesis contribute to both goals, more knowledge and 
transparency over food additive E171 and contributing in identifying underlying causes of 
the western diet leading to an increase of development of CRC.  
 
II- Target group 
Outside of the academic community, the industries using TiO2 in their products 
are interested by our research results. Due to the pressure of the consumers, certain 
industries are investigating the potential adverse effects of TiO2 and opting for 
alternatives. Indeed, because of the incertitude regarding the potential adverse effects of 
TiO2, some big companies have already claimed that they stopped using TiO2 in all or some 
of their products like Lutti®, Verquin®, and Dunkin’ Brands, Inc®. Furthermore, the 
possible changes in the regulation of E171 are well monitored by the industries and E171 
is considered as an example of what could also happen with other food additives.  
 
Additionally, the national organisation like Anses (Agence nationale de sécurité 
sanitaire de l'alimentation, de l'environnement et du travail), NVWA (Nederlandse 
Voedsel- en Warenautoriteit), BfR (Bundesinstitut für Risikobewertung), and FDA (Food 
and Drug Administration) as well as regulators are also interested by the results of this 
thesis. Following the change of classification of TiO2 by the IARC in 2010 from non-
carcinogen to possible carcinogen (group 2B) concerns of the different routes of exposure 
like ingestion rose. Therefore, in 2016, the EFSA made a re-evaluation of TiO2 as a food 
additive (5). Based on the available genotoxicity database, EFSA concluded that, 
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absorption, distribution, and excretion of micro- and nanosized TiO2 particles after oral 
exposure are unlikely to represent a genotoxic hazard in vivo. In addition, in June 2017, 
the risk assessment committee of the European Chemical Agency (ECHA) classified TiO2 as 
a suspected human carcinogen (category 2) via inhalation (6). Furthermore, national 
organisation could include the results of this thesis in a risk assessment which could lead 
to possible changes of the use of TiO2 in food products.  
 
The research presented in this thesis is of interest to the whole population for all 
age groups. Indeed, TiO2 is present in various food products from dairy products (milk, 
cheese, and ice cream), milk replacements (powdered milk), sweets (M&M’s®, Mentos®, 
chewing-gums, and cookies), drinks (soft drinks, sport drinks, and syrups), dressings and 
sauces (salad dressings), and food supplements (multivitamin pills) (7-11). The exposure 
varies depending on the age group. Children are the most exposed to TiO2 due to their 
higher ingestion of sweets and toothpaste. Depending on the diet (US, UK, Dutch or a 
global European diet) the estimation ranged from 0.67 mg TiO2/kgbw/day in the 
Netherlands (children between 2-6 years old) to 5.5 mg/kgbw/day as estimated by the 
European Food Safety Authority (EFSA) (children between 3 and 9 years old). For the 
adults, the estimated concentrations were lower from 0.17 mg TiO2/kgbw/day between 7-
69 years in the Netherlands to 4.1 and 4.0 mg TiO2/kgbw/day for adolescents (10-17 years 
old) and adults (18-64 years old) respectively as estimated by the EFSA (5,10,11). 
 
III- Translation of the results 
The results from this thesis provide an opportunity for further research and a 
basis for a future risk assessment of TiO2 as food additive. Following new evidence 
provided in the last 2 years, the European Commission asked the EFSA to include 4 new 
studies in their re-evaluation of titanium dioxide as food additive. In addition, due to the 
new evidence about the adverse effects of E171, the French government asked the Anses 
to perform more research about potential adverse effects of ingestion of E171.  
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IV- Innovation of the research 
When the IARC decided, in 2010, to re-evaluate TiO2 to assess its potential impact 
on development of cancer, enough evidence was found from the inhalation route where 
tumours in the lungs of rats were observed (12). Based on these results, the IARC decided 
to change the classification of TiO2 from non-carcinogen to possible carcinogen to 
humans. During this evaluation, the IARC stated that there was not enough evidence 
regarding the other routes of exposure (dermal contact and ingestion) as well as the 
modes of action of TiO2 underlying these adverse effects (kinetics, in vivo and in vitro 
genotoxicity, cytotoxicity, presence of inflammation, and penetration of TiO2 through the 
skin). 
 
Since the change of classification by the IARC, the ingestion route via the 
ingestion of food products containing E171 has been studied. Within these studies, a 
collaborative group has observed that after ingestion of 5 mg/kgbw/day of E171 for 10 
weeks in a chemically induced colorectal cancer mouse model with azoxymethane (AOM) 
and dextran sodium sulphate (DSS), the number of tumour was increased when E171 was 
also orally administrated (13). From the results of this study, the mechanisms behind this 
development of tumours were studied. Chapter 2, 3, and 4 present the first whole-
genome mRNA analysis of the colon of mice after oral exposure to E171 in 3 different 
mouse models: a normal BALB/c, a chemically induced CRC with AOM/DSS, and a 
transgenic model. These analyses provide potential underlying molecular mechanisms 
modulated after oral exposure to E171. The mechanisms of in vitro genotoxicity, 
cytotoxicity and oxidative stress on a human colon cell line (Caco-2) in Chapter 5 
confirmed previous findings of other cells lines. Additionally, the contribution of each 
fraction of E171 was identified and shows that the NPs and the MPs fraction contribute to 
these adverse effects. The mechanisms were also investigated in vitro in Caco-2 cells in 
Chapter 6 to assess the contribution of the MPs and NPs at the mRNA level. To the best of 
our knowledge, this was the first time that the contribution of each fraction of E171 was 
assessed.  
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V- Implementation of the valorisation  
The knowledge acquired in this thesis offers a potential mechanistic explanation 
of the enhancement of tumours in the colon of mice and can be used for further 
translational and applied purposes, for instance for risk assessment in food safety of food 
additive E171. With this risk assessment, competent regulatory authorities could decide if 
policy changes are necessary. Risk assessments may set conditions for more healthy food. 
Consumers will be better informed regarding products that are added in the food. 
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